期刊文献+

真性红细胞增多症转化为急性白血病并发结肠癌一例 被引量:2

原文传递
导出
摘要 患者 男性,73岁,干部,于1986年因发现皮肤色泽变红而就诊,查血常规示血色素210g/L,血小板1000×10^9/L,白细胞14×10^9/L,超声示脾脏肿大,中性粒细胞碱性磷酸酶积分120,行骨髓涂片示红系增生极度活跃,粒系以及巨核系增生活跃,骨髓活检示纤维组织轻度增生。患者无慢性心肺疾病史,无高原久居史,无烟酒嗜好,诊断真性红细胞增多症(PV)。给予白消安(具体剂量不详)治疗8个月后,白细胞、血色素以及血小板恢复到正常水平,脾脏也回缩到正常大小,
出处 《白血病.淋巴瘤》 CAS 2009年第8期493-493,共1页 Journal of Leukemia & Lymphoma
  • 相关文献

同被引文献27

  • 1申徐良,陈方平,魏武,张梅香,史文芝,秦小琪,徐洪亮.bcr-abl阴性骨髓增生性疾病患者JAK2V617F点突变检测的临床意义[J].白血病.淋巴瘤,2008,17(2). 被引量:1
  • 2James C, Ugo V, Le Cou e dic JP, et al. A unique clonal JAK2 mutation leading to constitutive signaling causes polycythaemi a vera. Nature, 2005, 434:1144-1148.
  • 3Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet, 2005, 365: 1054-1061.
  • 4Levine RL, Wadleigh M, Cools J, et al. Aetiviting mutation in the tyrosine kinase JAK2 polyeythaemia vera,essential thromboeythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell, 2005, 7: 387- 397.
  • 5Kralovics R, Passamonti F, Buser AS, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med, 2005, 352: 1779-1790.
  • 6Tefferi A. Classification, diagnosis and magagemant of myeloproliferative disorders in the JAK2617F era. Hematology Am Soc Hematol Educ Program, 2006: 240-245.
  • 7Skoda R. The genec basis ofmyeloproliferative disorders. Hematology Am Soc Hematol Educ Program, 2007: 1-10.
  • 8Prchal JT. Philadelphia chromosome-negativemyeloproliferative disorders: an historical perspective. Hematology Am Soc Hematol Educ Program, 2008: 68.
  • 9James C. The JAK2V617F mutation in polycythemia vera and other myeloproliferative disorders: one mutatio for three Diseases? Hematology Am Soc Hematol Educ Program, 2008: 69-75.
  • 10Levine RL, Wernig G. Role of JAK-STAT signnaling in the pathogenesis of myeloproliferative disorders. Hematology Am Soc Hematol Educ Program, 2006: 233-239.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部